}}Coronavirus disease 2019 – United Perfonmance

United Perfonmance

  • Home
  • Company
  • It Solutions
  • Capability Statement
  • Contact

Coronavirus disease 2019

miércoles, 24 junio 2026 / Publicado en Public

Coronavirus disease 2019

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

What you can read next

Avancerade tekniker för att maximera vinst i spelbranschen
Vinkit ja niksit voittamisen maksimoimiseksi uhkapelissä
¿Son ciertos los mitos sobre el juego que todos creen

Deja una respuesta Cancelar la respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Search for posts

Recent Posts

  • Diese umfassenden Bonusbedingungen & Umsatzanforderungen sollen auf der offiziellen Site uberpruft man sagt, sie seien

    0 comments
  • In ein Organis ion im griff haben diese einfach aufgrund der Eintragung inside einem PayPal-Bankverbindung der- ferner amortisieren

    0 comments
  • Im zuge dessen loath ihr Anbieter zu handen gebuhrend Chancen gesorgt, ebendiese allen Spielerbedurfnissen vollziehen durften

    0 comments

Recent Comments

  • A WordPress Commenter en Hello world!

SITE

  • Home
  • Company
  • It Solutions
  • Capability Statement
  • Contact

IT SOLUTIONS

  • VOICE / DATA SOLUTIONS
  • FIBER OPTIC INSTALLATION
  • AISLE CONTAINMENT SYSTEMS
  • DATA CENTERS
  • AV SYSTEM

CONTACT

Monday - Friday 8:30am - 05:00pm

(703) 296-2251

info@upcincorp.com

CAPABILITY STATEMENT PDF

© UPC - Design by OMNI Agencia de Marketing Digital

SUBIR